Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of decentered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 2.
de Witte PB, van Bergen CJA, de Geest BL, Willeboordse F, van Linge JH, den Hartog YM, Margret M H P Foreman-van Drongelen M, Pereboom RM, Robben SGF, Burger BJ, Witlox MA, Witbreuk MMEH. de Witte PB, et al. Among authors: den hartog ym. EFORT Open Rev. 2022 Aug 4;7(8):542-553. doi: 10.1530/EOR-21-0126. EFORT Open Rev. 2022. PMID: 35924650 Free PMC article. Review.
Treatment of centered developmental dysplasia of the hip under the age of 1 year: an evidence-based clinical practice guideline - Part 1.
van Bergen CJA, de Witte PB, Willeboordse F, de Geest BL, Foreman-van Drongelen MMMHP, Burger BJ, den Hartog YM, van Linge JH, Pereboom RM, Robben SGF, Witlox MA, Witbreuk MMEH. van Bergen CJA, et al. Among authors: den hartog ym. EFORT Open Rev. 2022 Jul 5;7(7):498-505. doi: 10.1530/EOR-21-0125. EFORT Open Rev. 2022. PMID: 35900213 Free PMC article. Review.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, de Rooij DM, van Meerloo J, Cloos J, Kootstra NA, Wouters D, Weijers SS, van Leeuwen EMM, Bontkes HJ, Tonouh-Aajoud S, Heemskerk MHM, Sanders RW, Roelandse-Koop E, Hofsink Q, Groen K, Çetinel L, Schellekens L, den Hartog YM, Toussaint B, Kant IMJ, Graas T, de Pater E, Dik WA, Engel MD, Pierie CRN, Janssen SR, van Dijkman E, Poniman M, Burger JA, Bouhuijs JH, Smits G, Rots NY, Zweegman S, Kater AP, van Meerten T, Mutsaers PGNJ, van Doesum JA, Broers AEC, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Haggenburg S, et al. Among authors: den hartog ym. Blood Adv. 2022 Mar 8;6(5):1537-1546. doi: 10.1182/bloodadvances.2021006917. Blood Adv. 2022. PMID: 35114690 Free PMC article. Clinical Trial.
12 results